Phase I dose escalation, pharmacokinetic and pharmacodynamic study of naptumomab estafenatox alone in patients with advanced cancer and with docetaxel in patients with advanced non-small-cell lung cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/19636016

J. Clin. Oncol. 2009 Sep 1 27 25 4116-23

Download in:

View as

Triples

General Info

PMID
19636016